Woman depicting a cancer patient.

 

For patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two therapies for metastatic disease

I’M TAKING ON mTNBC

What is TRODELVY?

TRODELVYTM (sacituzumab govitecan-hziy) is a prescription medicine used to treat adults with a certain type of breast cancer known as triple-negative (HR and HER2 negative) that has spread to other parts of the body (metastatic) and who received at least two therapies for metastatic disease.

TRODELVY is approved based on medical studies that measured how many patients responded and how long they responded. Continued approval may depend on benefit demonstrated in additional medical studies.

It is not known if TRODELVY is safe and effective in people with moderate or severe liver problems or in children.

Not an actual patient.

Breast cancer awareness month